| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.4M | -28.5% |
| Cost of Revenue | $4.6M | +11.7% |
| R&D Expense | $6.8M | +11.4% |
| SG&A Expense | $15.8M | -4.3% |
| Operating Income | -$20.8M | -16.9% |
| Interest Expense | $857K | -19.5% |
| Pre-tax Income | -$21.6M | -26.1% |
| Income Tax | $11K | -51.8% |
| Net Income | -$21.6M | -26.0% |
| EPS (Basic) | -$24.28 | +18.1% |
| EPS (Diluted) | -$24.28 | +18.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.2M | +27.2% |
| Accounts Receivable | $1.4M | -32.1% |
| Inventory | $909K | -54.3% |
| Current Assets | $15.7M | -42.4% |
| Total Assets | $17.8M | -41.6% |
| Current Liabilities | $8.3M | -16.8% |
| Long-term Debt | $5.2M | +0.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.4M | -11.5% |
| Capital Expenditures | $23K | -96.4% |
| Investing Cash Flow | $12.4M | +286.4% |
| Financing Cash Flow | $8.6M | -17.2% |
| Free Cash Flow | -$18.4M | -7.5% |
| Total Liabilities |
| $12.4M |
| -38.3% |
| Stockholders' Equity | $5.4M | -48.2% |